Does ANAKINRA Cause Product dose omission issue? 864 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 864 reports of Product dose omission issue have been filed in association with ANAKINRA (Kineret). This represents 7.1% of all adverse event reports for ANAKINRA.
864
Reports of Product dose omission issue with ANAKINRA
7.1%
of all ANAKINRA reports
4
Deaths
198
Hospitalizations
How Dangerous Is Product dose omission issue From ANAKINRA?
Of the 864 reports, 4 (0.5%) resulted in death, 198 (22.9%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANAKINRA. However, 864 reports have been filed with the FAERS database.
What Other Side Effects Does ANAKINRA Cause?
Off label use (4,317)
Drug ineffective (3,368)
Pain (1,344)
Condition aggravated (1,339)
Rheumatoid arthritis (1,300)
Drug intolerance (946)
Joint swelling (921)
Injection site pain (879)
Arthralgia (850)
Pyrexia (782)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ANAKINRA Alternatives Have Lower Product dose omission issue Risk?
ANAKINRA vs ANAMORELIN
ANAKINRA vs ANASTROZOLE
ANAKINRA vs ANDEXANET ALFA
ANAKINRA vs ANDROGEL
ANAKINRA vs ANETHOLTRITHION